Lymphangiogenesis: in vitro and in vivo models

被引:70
|
作者
Bruyere, Francoise [1 ]
Noel, Agnes [1 ]
机构
[1] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, CHU Sart Tilman B23, B-4000 Liege, Belgium
来源
FASEB JOURNAL | 2010年 / 24卷 / 01期
关键词
lymphatic endothelial cell; lymphedema; metastatic dissemination; graft rejection; LYMPHATIC ENDOTHELIAL-CELLS; GROWTH-FACTOR-C; VEGF-C; NODE METASTASIS; INTERSTITIAL FLOW; TUMOR LYMPHANGIOGENESIS; FACTOR RECEPTOR-3; THORACIC-DUCT; GENE-THERAPY; INTRATUMORAL LYMPHANGIOGENESIS;
D O I
10.1096/fj.09-132852
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lymphangiogenesis, the formation of new lymphatic vessels from preexisting ones, is an important biological process associated with diverse pathologies, such as metastatic dissemination and graft rejection. In addition, lymphatic hypoplasia characterizes lymphedema, usually a progressive and lifelong condition for which no curative treatment exists. Much progress has been made in recent years in identifying molecules specifically expressed on lymphatic vessels and in the setting up of in vitro and in vivo models of lymphangiogenesis. These new tools rapidly provided an abundance of information on the mechanisms underlying lymphatic development and the progression of diseases associated with lymphatic dysfunction. In this review, we describe the common in vitro and in vivo models of lymphangiogenesis that have proven suitable for investigating lymphatic biology and the interactions occurring between lymphatic vessels and other cells, such as immune cells and cancer cells. Their rationales and limitations are discussed and illustrated by the most informative findings obtained with them.-Bruyere, F., Noel, A. Lymphangiogenesis: in vitro and in vivo models. FASEB J. 24, 8 - 21 (2010). www.fasebj.org
引用
收藏
页码:8 / 21
页数:14
相关论文
共 50 条
  • [21] In vivo and in vitro models for breast carcinogenesis
    Calaf, Gloria M.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S27 - S27
  • [22] Experimental models of angiogenesis (in vitro and in vivo)
    Tucker, GC
    THERAPIE, 2001, 56 (05): : 473 - 481
  • [23] In vitro and in vivo models of Pneumocystis carinii
    Bartlett, MS
    Queener, SF
    Shaw, MM
    Durant, PJ
    Lee, CH
    Smith, JW
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1997, 44 (06) : 51S - 51S
  • [24] In vitro and ex vivo models of adipocytes
    Dufau, Jeremy
    Shen, Joanne X.
    Couchet, Morgane
    Barbosa, Thais De Castro
    Mejhert, Niklas
    Massier, Lucas
    Griseti, Elena
    Mouisel, Etienne
    Amri, Ez-Zoubir
    Lauschke, Volker M.
    Ryden, Mikael
    Langin, Dominique
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (05): : C822 - C841
  • [25] Biotechnology - In vitro Models for In vivo Research
    Bols, P. E. J.
    REPRODUCTION IN DOMESTIC ANIMALS, 2009, 44 : 63 - 64
  • [26] Validation of in vitro in vivo correlation models
    Young, D
    Dowell, JA
    Piscitelli, DA
    Devane, J
    IN VITRO-IN VIVO CORRELATIONS, 1997, 423 : 87 - 91
  • [27] Taenia crassiceps: in vivo and in vitro models
    Willms, Kaethe
    Zurabian, Rimma
    PARASITOLOGY, 2010, 137 (03) : 335 - 346
  • [28] In vitro and in vivo models of bacterial biofilms
    Yasuda, H
    Koga, T
    Fukuoka, T
    BIOFILMS, 1999, 310 : 577 - 595
  • [29] In vitro and in vivo models for the study of urolithiasis
    Khan, Aslam
    UROLOGIA JOURNAL, 2018, 85 (04) : 145 - 149
  • [30] Chrysin Inhibits Lymphangiogenesis in Vitro
    Prangsaengtong, Orawin
    Athikomkulchai, Sirivan
    Xu, Jiuxiang
    Koizumi, Keiichi
    Inujima, Akiko
    Shibahara, Naotoshi
    Shimada, Yutaka
    Tadtong, Sarin
    Awalee, Suresh
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (04) : 466 - 472